|
2022
|
Invention
|
Antimalarial agents.
Provided are methods of treating malaria comprising administration of compo... |
|
|
Invention
|
Antimalarial agents. PlasmodiumPlasmodium infection, and for treating malaria. Also provided are ... |
|
|
Invention
|
Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenza.
The prese... |
|
|
Invention
|
Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenza. The presen... |
|
|
Invention
|
Il4i1 inhibitors and methods of use.
The invention discloses a synthesizing method of benzimidaz... |
|
|
Invention
|
Il4i1 inhibitors and methods of use. Described herein are compounds of Formula (I) or a pharmaceu... |
|
2021
|
Invention
|
Antimalarial agents. Provided are methods of treating malaria comprising administration of compou... |
|
|
Invention
|
Il4i1 inhibitors and methods of use. Described herein are compounds of Formula I or a pharmaceuti... |
|
2020
|
Invention
|
Antimalarial agents. Plasmodium infection, and for treating malaria. Also provided are methods of... |
|
|
Invention
|
Antimalarial agents. Methods of treating malaria comprising administration of compounds of Formul... |
|
2019
|
Invention
|
Antimalarial agents. The present invention provides methods of treating malaria comprising admini... |
|
|
Invention
|
3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor. Th... |
|
|
Invention
|
Antimalarial agents. Methods for treating malaria comprises administration of compounds of Formul... |
|
2018
|
Invention
|
3-(1h-pyrazol-4-yl)pyridine allosteric modulators of m4 muscarinic acetylcholine receptor. Provid... |
|
|
Invention
|
5-(pyridin-3-yl)oxazole allosteric modulators of the m4 muscarinic acetylcholine receptor. The pr... |
|
2017
|
Invention
|
Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor. Th... |
|
|
Invention
|
3-(1h-pyrazol-4-yl)pyridine allosteric modulators of m4 muscarinic acetylcholine receptor. Disclo... |
|
|
Invention
|
5-(pyridin-3-yl)oxazole allosteric modulators of m4 muscarinic acetylcholine receptor. Provided a... |
|
2016
|
Invention
|
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the m4 muscarinic acetylcholi... |
|
|
Invention
|
6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors. The present invention is direct... |
|
2015
|
Invention
|
6, 7-dihydro-5h-pyrrolo [3, 4-b] pyridin-5-oneallosteric modulators of the m4 muscarinic acetylch... |
|
|
Invention
|
3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor. T... |
|
|
Invention
|
Erk inhibitors. The present invention provides a compound of Formula (I) or the pharmaceutically ... |
|
|
Invention
|
Inhibitors of hif prolyl hydroxylase.
The present invention concerns compounds of formula I or p... |
|
|
Invention
|
Inhibitors of hif prolyl hydroxylase. The present invention concerns a compound of formula I or a... |
|
|
Invention
|
Process for making tetracyclic heterocycle compounds. The present invention is directed to a proc... |
|
|
Invention
|
Dihydropyrazolopyrimidinone compounds as pde2 inhibitors. The present invention is directed to di... |
|
|
Invention
|
Trka kinase inhibitors, compositions and methods thereof. The present invention is directed to si... |
|
2014
|
Invention
|
Inhibitors of hif prolyl hydroxylase. Disclosed are a compound of formula I or a pharmaceutically... |
|
|
Invention
|
Inhibitors of hif prolyl hydroxylase. The present invention concerns compounds of formula I or ph... |
|
|
Invention
|
Inhibitors of hif prolyl hydroxylase. The present invention concerns compounds of formula I or a ... |
|
|
Invention
|
Inhibitors of hif prolyl hydroxylase. Disclosed are compounds of formula I or pharmaceutically ac... |
